Clinical value of serum anti-centromere protein F antibody in breast cancer

Wang Yanping; Tang Dijiao; Maimaitiyili Nuerbiye; Zou Lin; Chen Pu

doi:10.13406/j.cnki.cyxb.003588

您当前的位置：

首页 >

文章列表页 >

Clinical value of serum anti-centromere protein F antibody in breast cancer

Clinical research | 更新时间：2025-10-21

- Clinical value of serum anti-centromere protein F antibody in breast cancer
- Journal of Chongqing Medical University Vol. 49, Issue 9, Pages: 1188-1192(2024)
- 作者机构：
  
  重庆医科大学附属第一医院检验科，重庆 400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003588
  CLC： R392.7
- Received：31 December 2023，
  
  Revised：2024-05-02，
  
  Accepted：15 May 2024，
  
  Published：28 September 2024
- 稿件说明：
移动端阅览
王艳萍,唐笛娇,努尔比耶·买买提依力,等.血清抗着丝粒蛋白F抗体在乳腺癌中的临床价值探讨[J].重庆医科大学学报,2024,49(9):1188-1192.

Wang Yanping,Tang Dijiao,Nuerbiye Maimaitiyili,et al.Clinical value of serum anti-centromere protein F antibody in breast cancer[J].Journal of Chongqing Medical University,2024,49(9):1188-1192.
王艳萍,唐笛娇,努尔比耶·买买提依力,等.血清抗着丝粒蛋白F抗体在乳腺癌中的临床价值探讨[J].重庆医科大学学报,2024,49(9):1188-1192. DOI： 10.13406/j.cnki.cyxb.003588.

Wang Yanping,Tang Dijiao,Nuerbiye Maimaitiyili,et al.Clinical value of serum anti-centromere protein F antibody in breast cancer[J].Journal of Chongqing Medical University,2024,49(9):1188-1192. DOI： 10.13406/j.cnki.cyxb.003588.

摘要

目的

探讨血清抗着丝粒蛋白F抗体（anti-centromere protein F antibody，anti-CENPF）在乳腺癌中的临床价值。

方法

收集100例初诊乳腺癌（breast cancer，BC）患者、40例乳腺良性疾病（non breast cancer，non-BC）患者和40名健康体检者（healthy control，HC）血清，采用酶联免疫吸附试验检测血清中的anti-CENPF水平，同时化学发光法测定血清糖类抗原153（carbohydrate antigen 153，CA153）的水平。

结果

BC组血清anti-CENPF水平高于non-BC组和HC组，差异有统计学意义（

0.05）。anti-CENPF和CA153诊断乳腺癌中的曲线下面积（area under the curve，AUC）分别为0.714和0.672，两者联合检测的AUC为0.739。有淋巴结转移、远处转移或者人表皮生长因子受体2（human epidermal growth factor receptor-2，HER-2）阴性的乳腺癌患者血清anti-CENPF浓度明显升高（

0.05）。不同肿瘤大小、临床分期、分子分型乳腺癌患者血清anti-CENPF水平比较，差异有统计学意义（

0.05）。组间比较显示Ⅳ期和Ⅲ期血清anti-CENPF浓度高于Ⅰ期和Ⅱ期，HER-2过表达型、Luminal B型血清anti-CENPF水平低于三阴性乳腺癌（triple negative breast cancer，TNBC）患者。雌激素受体（receptors estrogen，ER）阳性的乳腺癌患者中，HER-2阴性组的anti-CENPF浓度高于HER-2阳性组，差异有统计学意义（

=0.026）。

结论

血清anti-CENPF在乳腺癌的诊断、临床分期及分子分型中发挥了重要作用，其水平可能与乳腺癌预后呈负相关，有望成为乳腺癌潜在的疾病标志物。

Abstract

Objective

To investigate the clinical value of serum anti-centromere protein F antibody（anti-CENPF） in breast cancer.

Methods

Serum samples were collected from 100 breast cancer patients（BC group），40 patients with benign breast disease（non-BC group），and 40 healthy controls（HC group）. Enzyme-linked immunosorbent assay was used to measure the serum level of anti-CENPF，and chemiluminescence was used to measure the serum level of carbohydrate antigen 153（CA153）.

Results

The BC group had a significantly higher serum level of anti-CENPF than the non-BC group and the HC group（

0.05）. The receiver operating characteristic（ROC） curve analysis showed that anti-CENPF and CA153 had an area under the ROC curve（AUC） of 0.714 and 0.672，respectively，in the diagnosis of breast cancer，and the combination of anti-CENPF and CA153 had an AUC of 0.739. There was a significant increase in the concentration of serum anti-CENPF in breast cancer patients with lymph node metastasis，distant metastasis，or negative human epidermal growth factor receptor 2（HER-2）（

0.05）. There was a significant difference in the serum level of anti-CENPF between breast cancer patients with different tumor sizes，clinical stages，and molecular types（

0.05）. Comparison between groups showed that patients with stage Ⅲ/Ⅳ breast cancer had a significantly higher serum level of anti-CENPF than those with stage Ⅰ/Ⅱ breast cancer，and patients with HER-2 overexpression or Luminal B type breast cancer had a significantly lower serum level of anti-CENPF than those with triple negative breast cancer. Among patients with estrogen receptor-positive breast cancer，the HER-2 negative group had a significantly higher concentration of anti-CENPF than the HER-2 positive group（

=0.026）.

Conclusion

Serum anti-CENPF plays an important role in the diagnosis，clinical staging，and molecular typing of breast cancer，and the level of anti-CENPF may be negatively correlated with the prognosis of breast cancer. Therefore，it is expected to become a potential disease marker for breast cancer.

关键词

Keywords

references

Trapani D ， Ginsburg O ， Fadelu T ， et al . Global challenges and policy solutions in breast cancer control [J ] . Cancer Treat Rev ， 2022 ， 104 ： 102339 ．

张志锋，孙业富，沈预程 . 血清TFF1检测在乳腺癌诊断及预后评估中的价值 [J ] . 中国免疫学杂志， 2019 ， 35 （ 13 ）： 1627 - 1630 ．

Zhang ZF ， Sun YF ， Shen YC . Value of serum TFF1 in diagnosis and prognosis of breast cancer [J ] . Chin J Immunol ， 2019 ， 35 （ 13 ）： 1627 - 1630 ．

Seale KN ， Tkaczuk KHR . Circulating biomarkers in breast cancer [J ] . Clin Breast Cancer ， 2022 ， 22 （ 3 ）： e319 - e331 ．

邱晓阳，吴　璇，刘君，等 . 外周血循环肿瘤细胞联合CA153检测在乳腺癌筛查及分期预测中的应用价值 [J ] . 华中科技大学学报（医学版）， 2020 ， 49 （ 3 ）： 331 - 337 ．

Qiu XY ， Wu X ， Liu J ， et al . Application value of peripheral blood circulating tumor cells combined with CA153 detection in breast cancer screening and stage prediction [J ] . Acta Med Univ Sci Technol Huazhong ， 2020 ， 49 （ 3 ）： 331 - 337 ．

Zhang J ， Wang ZY ， Liu ZM ， et al . CENPF promotes the proliferation of renal cell carcinoma in vitro [J ] . Transl Androl Urol ， 2023 ， 12 （ 2 ）： 320 - 329 ．

李宇阳，傅培铃，钟国栋，等 . 着丝粒蛋白-F在胰腺导管腺癌中的表达及临床意义 [J ] . 华中科技大学学报（医学版）， 2023 ， 52 （ 6 ）： 771 - 780 ．

Li YY ， Fu PL ， Zhong GD ， et al . Expression and clinical significance of centromere protein-F in pancreatic ductal adenocarcinoma [J ] . Acta Med Univ Sci Technol Huazhong ， 2023 ， 52 （ 6 ）： 771 - 780 ．

Fritzler MJ ， Rattner JB ， Luft LM ， et al . Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins（CENP） and the emerging importance of antibodies to CENP-F [J ] . Autoimmun Rev ， 2011 ， 10 （ 4 ）： 194 - 200 ．

Tan PH ， Ellis I ， Allison K ， et al . The 2019 World Health Organization classification of tumours of the breast [J ] . Histopathology ， 2020 ， 77 （ 2 ）： 181 - 185 ．

Zhu HL ， Doğan BE . American joint committee on cancer’s staging system for breast cancer，eighth edition：summary for clinicians [J ] . Eur J Breast Health ， 2021 ， 17 （ 3 ）： 234 - 238 ．

中国抗癌协会乳腺癌专业委员会 . 中国抗癌协会乳腺癌诊治指南与规范（2021年版） [J ] . 中国癌症杂志， 2021 ， 31 （ 10 ）： 954 - 1040 ．

Breast Cancer Expert Committee of China Anti-Cancer Association . Guidelines and norms for diagnosis and treatment of breast cancer of China Anti-Cancer Association（2021 edition） [J ] . China Oncol ， 2021 ， 31 （ 10 ）： 954 - 1040 ．

Goldhirsch A ， Wood WC ， Coates AS ， et al . Strategies for subtypes：dealing with the diversity of breast cancer：highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J ] . Ann Oncol ， 2011 ， 22 （ 8 ）： 1736 - 1747 ．

Liang YR ， Zhang HW ， Song XJ ， et al . Metastatic heterogeneity of breast cancer：Molecular mechanism and potential therapeutic targets [J ] . Semin Cancer Biol ， 2020 ， 60 ： 14 - 27 ．

Kim EJ ， Park HS ， Kim JY ， et al . Assessment of the prognostic staging system of American joint committee on cancer 8th edition for breast cancer：comparisons with the conventional anatomic staging system [J ] . J Breast Cancer ， 2020 ， 23 （ 1 ）： 59 - 68 ．

刘荫华，周　斌，辛灵，等 . 正确认识AJCC第8版乳腺癌预后分期的临床价值 [J ] . 国际外科学杂志， 2017 ， 44 （ 3 ）： 149 - 151 ．

Liu YH ， Zhou B ， Xin L ， et al . Clinical value of correctly understanding the prognosis staging of AJCC 8th edition breast cancer [J ] . Int J Surg ， 2017 ， 44 （ 3 ）： 149 - 151 ．

Temian DC ， Pop LA ， Irimie AI ， et al . The epigenetics of triple-negative and basal-like breast cancer：current knowledge [J ] . J Breast Cancer ， 2018 ， 21 （ 3 ）： 233 - 243 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Potential value of miR-200a-3p as a biomarker for the diagnosis and prognosis of colorectal cancer

Clinical features，diagnosis，and treatment of chlamydia psittaci pneumonia based on metagenomic next-generation sequencing: an analysis of 15 cases

Diagnostic value of serum CD147 level in ovarian cancer and its effect on prognosis and recurrence

Bioinformatics analysis of GNG4 and TIMP1 on diagnostic and prognosis significance in colon cancer

Correlation between coronary heart disease and intestinal flora

Related Author

Cao Yongqing

Sui Qian

Huang Fang

Li Ke

Liu Jieqiong

Yao Yali

Liu Yanquan

Lin Jie

Related Institution

Department of Hematology and Oncology，Changsha First Hospital & Changsha Hospital Affiliated to Xiangya School of Medicine，Central South University

Department of Gynecology，Changsha First Hospital & Changsha Hospital Affiliated to Xiangya School of Medicine，Central South University

Department of Intensive Medicine（Comprehensive ICU），The First Affiliated Hospital of Gannan Medical University，Jiangxi Provincial Key Clinical Specialized Department of Intensive Medicine

Department of Blood Transfusion

Department of Clinical Laboratory

⁰